Using Antibiotics Wisely. Making Them Responsibly.

NORTHAMPTON, MA / ACCESS Newswire / November 25, 2025 / You wake up with a sore throat and a fever. The doctor gives you a prescription for antibiotics. A few days later, you feel better, so you stop taking them.

Harmless? Not quite.

Stopping antibiotics early gives bacteria in our bodies the chance to adapt and resist the very medicines designed to get rid of them. And that is fueling one of the most serious public health threats of our time: Antimicrobial resistance (AMR).

With AMR, even common infections can become life-threatening. AMR is already responsible for millions of deaths globally each year. The good news is, there are simple, powerful ways we can help slow it down:

  • Always finish the full course of antibiotics, even if you feel better.

  • Never share antibiotics with others.

  • Dispose of leftover medications properly-don’t flush them or throw them in the trash.

  • Trust your doctor’s advice-don’t ask for antibiotics if you don’t need them.

From the Manufacturing Site to the Pharmacy Counter

We’re doing our part to address AMR by manufacturing our medicines responsibly, holding suppliers accountable and educating patients and healthcare professionals around the world.

In the last two years, Teva has earned two certifications from the British Standards Institution (BSI) for responsible antibiotic manufacturing. We’re monitoring our sites to prevent antibiotic residues from entering our environment-and we’re helping our suppliers do the same. Because when antibiotics linger in places like wastewater, they give bacteria the chance to adapt and become more resistant.

Reaching Patients Where They Are

To help improve how antibiotics are prescribed and used, we partner with Clarivate to conduct pilot programs, tailored to the local populations and healthcare systems.

Through our pilot in Germany, patients received short messages on pharmacy screens when they picked up their antibiotics, and more than 389,000 digital messages were sent to pharmacists to remind patients how to use antibiotics safely. The effort resonated: 77% of pharmacists said the materials helped them have meaningful conversations with patients about antibiotics.

In Kenya, our program engages physicians within their Electronic Health Record (EHR) systems, reminding them about responsible prescribing practices in real time. Patients also receive SMS messages encouraging them to complete their treatment, in their local language. The program revealed that many patients still believe antibiotics can treat the common cold, while limited access to diagnostic tools can make accurate prescribing more difficult-both of which can increase the risk of AMR.

There’s still work to do, and everyone has a role to play. Let’s protect the healing power of antibiotics so they can continue to protect us.

View additional multimedia and more ESG storytelling from Teva Pharmaceutical on 3blmedia.com.

Contact Info:
Spokesperson: Teva Pharmaceutical
Website: https://www.3blmedia.com/profiles/teva-pharmaceutical
Email: info@3blmedia.com

SOURCE: Teva Pharmaceutical

View the original press release on ACCESS Newswire

Staff

Recent Posts

Atropos Health Expands Oncology Precision Medicine Capabilities with Publication of New AI Algorithms for Rare Disease and Integration of ASCO Guidelines

Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…

55 minutes ago

USF and Old Dominion to Play in the 2025 StaffDNA Cure Bowl

PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…

58 minutes ago

The Dot Corp Expands Services With New Promotional Products & Apparel Division

IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…

58 minutes ago

Vaniam Group Launches Predictive Pathways: A New Capability for Anticipating Market-Shaping Signals

CHICAGO, Dec. 5, 2025 /PRNewswire/ -- Vaniam Group™, a category leader redefining medical communications, announced…

59 minutes ago

Biorep Technologies Announces First Successful Independent Research Use of the PRISM System in Islet Isolation

Results confirm reproducibility and research readiness for islet isolation of Biorep's next generation laboratory platform.MIAMI,…

59 minutes ago